A new episode of the Annals of Internal Medicine podcast looks at tirzepatide in type 2 diabetes treatment. Listen through for the full discussion.
Recap by typeshit. Post by Facebook on Facebook.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Nestlé is building nutrition products for GLP-1 users, and Circana says alcohol volumes are falling while high-protein, smaller-pack foods gain.
10:37
PBS NewsHour reports on the growing research into whether GLP-1 medications could help with addiction to alcohol and other drugs.
Loading…